NASDAQ:QTTB | Free Cash Flow | Q32 Bio Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$6.34M
2025-12-31-$6.18M$0.00-$6.18M-10.71%
2025-03-31-$12.48M
2024-12-31-$11.43M$2,000.00-$11.43M
2024-03-31-$14.55M$0.00-$14.55M-1414.09%
2023-12-31-$10.72M$0.00-$10.72M
2023-03-31-$12.5M$5,000.00-$12.5M
2022-12-31-$27.2M$9,000.00-$27.21M
2022-03-31-$30.68M$1.15M-$31.83M-34.56%
2021-12-31-$30.43M$338,000.00-$30.77M
2021-03-31-$29.82M$817,000.00-$30.64M
2020-12-31-$11.61M$955,000.00-$12.57M
2020-03-31-$25.85M$2.03M-$27.88M
2019-12-31-$26.33M$3.73M-$30.06M
2019-03-31-$17.87M$10.47M-$28.34M
2018-12-31-$8.08M$15.93M-$24.01M
2018-03-31-$11.04M$1.04M-$12.08M
2017-12-31$22.05M$336,735.00$21.71M
2017-03-31-$4.52M$848,433.00-$5.37M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$33.54M$0.00-$33.54M-112.48%
2024-12-31-$67.72M$75,000.00-$67.79M
2023-12-31-$18.68M$5,000.00-$18.68M
2022-12-31-$113.66M$1.29M-$114.95M
2021-12-31-$109.75M$2.4M-$112.15M
2020-12-31-$94.33M$3.73M-$98.07M
2019-12-31-$91.36M$21.83M-$113.19M
2018-12-31-$42.56M$24.94M-$67.5M
2017-12-31$6.48M$1.96M$4.52M